NCT00618735 Once or Twice Daily Administration of BIIB021 to Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00618319 An Open-Label, 18FDG-PET Pharmacodynamic Assessment of the Effect of BIIB021 in Subjects With Gastrointestinal Stromal Tumors (GIST) Status COMPLETED Phase PHASE2
NCT00618267 ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay. Status COMPLETED Phase N/A
NCT00616434 A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT00599274 Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis Status COMPLETED Phase N/A
NCT00588822 Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance Status TERMINATED Phase PHASE2
NCT00584935 Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid Status COMPLETED Phase PHASE1/PHASE2
NCT00578695 THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation Status COMPLETED Phase PHASE3
NCT00575068 Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00574041 How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose Status TERMINATED Phase PHASE4
NCT00559702 Safety Study of Natalizumab to Treat Multiple Sclerosis (MS) Status COMPLETED Phase PHASE1
NCT00555724 Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00550849 Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction Status TERMINATED Phase PHASE1/PHASE2
NCT00538343 RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases Status TERMINATED Phase PHASE2
NCT00536120 The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis Status COMPLETED Phase PHASE4
NCT00535314 Study of Two Dose Levels of RTA 402 in Patients With Advanced Malignant Melanoma Status WITHDRAWN Phase PHASE2
NCT00534261 Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? Status COMPLETED Phase PHASE4
NCT00531193 Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT00529438 RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies Status COMPLETED Phase PHASE1
NCT00529113 Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer Status TERMINATED Phase PHASE1